Jul. 26, 2018
MED-EL USA announced this week that the U.S. Food and Drug Administration (FDA) has granted de novo clearance for the BONEBRIDGE bone conduction hearing implant system for individuals 12 years and older who have been diagnosed with conductive hearing loss, mixed hearing loss, or single-sided deafness. Unlike many bone anchored hearing aids, which include an abutment that protrudes through the